NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANT
AssigneeCureVac AG
InventorsThomas KRAMPS, Söhnke VOSS, Jochen PROBST, Ingmar HOERR
Life of this patent
Estimating the term…
Loading patent…
AssigneeCureVac AG
InventorsThomas KRAMPS, Söhnke VOSS, Jochen PROBST, Ingmar HOERR
Estimating the term…
The present invention relates to nucleic acids of the general formula (I): (NuGlXmGnNv)a and derivatives thereof as an immunostimulating agent/adjuvant and to compositions containing same, optionally comprising an additional adjuvant. The present invention furthermore relates to a pharmaceutical composition or to a vaccine, each containing nucleic acids of formula (I) above and/or derivatives thereof as an immunostimulating agent, and optionally at least one additional pharmaceutically active component, e.g. an antigenic agent. The present invention relates likewise to the use of the pharmaceutical composition or of the vaccine for the treatment of cancer diseases, infectious diseases, allergies and autoimmune diseases etc. Likewise, the present invention includes the use of nucleic acids of the general formula (I): (NuGlXmGnNv)a and/or derivatives thereof for the preparation of a pharmaceutical composition for the treatment of such diseases.
1-25. (canceled)
An isolated nucleic acid molecule comprising at least 100 contagious nucleotides of SEQ ID NO:
Dependencies are inferred from the claim text.